Join us on Patreon! https://www.patreon.com/MichaelLustgartenPhD
Discount Links:
Epigenetic Testing: https://trudiagnostic.com/?irclickid=U-s3Ii2r7xyIU-LSYLyQdQ6…M0&irgwc=1
Use Code: CONQUERAGING
I’d place Sigmund et al. as one of my favorite papers that I have read this year! They leverage protein engineering to create genetically encoded nanocages which accumulate metals and appear as concentric circles when imaged by electron microscopy. Six classes of distinct “EMcapsulins” could be differentiated by training a machine learning model (a convolutional neural network) to recognize and classify them within images. Fusion of fluorescent protein domains to the EMcapsulins also allowed correlative imaging between fluorescence microscopy and electron microscopy. The authors demonstrated 3D imaging of EMcapsulins via serial section transmission electron microscopy and focused ion beam… More.
Multiplexable barcodes for electron microscopy are applied to brain imaging.
Year 2022 😗😁
Summary: A rare genetic mutation that causes blindness also appears to be associated with above-average intelligence, a new study reports.
Source: University of Leipzig
Continue reading “How a Gene Mutation Causes Higher Intelligence” »
The first gene therapy that can treat Duchenne muscular dystrophy (DMD) has been approved by the U.S. Food and Drug Administration; it will be marketed as Elevidys (delandistrogene moxeparvovec-rokl) by Sarepta Therapeutics Inc. Children aged four to five with the disorder and confirmed gene mutations will be eligible to receive the one-time treatment if insurers approve, as the cost is $3.2 million per patient.
DMD is caused by mutations in a gene called dystrophin, which results in a serious lack of functional dystrophin protein. The gene therapy works by sending a gene that can produce a shortened version of the dystrophin protein to patients; the company has termed it Elevidys micro-dystrophin.
Cardiovascular disease (CVD) is the leading cause of death worldwide and considered one of the most environmentally driven diseases. The role of DNA methylation in response to the individual exposure for the development and progression of CVD is still poorly understood and a synthesis of the evidence is lacking.
A systematic review of articles examining measurements of DNA cytosine methylation in CVD was conducted in accordance with PRISMA (preferred reporting items for systematic reviews and meta-analyses) guidelines. The search yielded 5,563 articles from PubMed and CENTRAL databases. From 99 studies with a total of 87,827 individuals eligible for analysis, a database was created combining all CpG-, gene-and study-related information. It contains 74,580 unique CpG sites, of which 1,452 CpG sites were mentioned in ≥ 2, and 441 CpG sites in ≥ 3 publications. Two sites were referenced in ≥ 6 publications: cg01656216 (near ZNF438) related to vascular disease and epigenetic age, and cg03636183 (near F2RL3) related to coronary heart disease, myocardial infarction, smoking and air pollution. Of 19,127 mapped genes, 5,807 were reported in ≥ 2 studies.
The technology could eventually revolutionize health care. We’ve seen CRISPR start to be used experimentally to treat children with cancer, for example. It is being explored for lots of genetic diseases. And last year, a company used CRISPR to try to treat a woman with dangerously high cholesterol.
But CRISPR could also transform farming, including aquaculture. This week, I wrote about researchers who inserted an alligator gene into catfish. The idea isn’t to make these fish more alligator-like, but to make them more resistant to disease. It turns out that alligators have a particular talent for fighting off infections.
These gene-edited fish, pigs, and other animals could soon be on the menu.
Continue reading “How CRISPR is making farmed animals bigger, stronger, and healthier” »
Busso also said we don’t yet know the long-term effects of these treatments on normal cells or what the long-term impact of killing zombie cells might be. Additionally, because zombie cells play an important role in wound healing, “We don’t want to remove all of them,” he said. “We don’t know the ideal regimen, daily versus weekly versus monthly.”
Hopefully, we won’t have to wait long for answers about the best way to get rid of zombie cells on the skin. “Major breakthroughs and contributions to delaying of the aging process are expected in the near future,” Busso said.
Although it’s still unclear whether zombie cells can be safely and effectively cleared from the skin, it is possible to prevent some zombie cells from forming in the first place. Collins explained that zombie cells are formed as the result of both biological and environmental factors. “The internal factors, like aging or genetic disease, are not so much within our control,” but the external factors can be controlled, she said.
Join us on Patreon! https://www.patreon.com/MichaelLustgartenPhD
Discount Links:
Epigenetic Testing: https://trudiagnostic.com/?irclickid=U-s3Ii2r7xyIU-LSYLyQdQ6…M0&irgwc=1
Use Code: CONQUERAGING
Continue reading “Epigenetic Age Test #6: My Youngest Data For Horvath, DunedinPACE” »
Dr David Sinclair talks about what epigenetic reprogramming can achieve in animal and human in this short. Please note that the links below are affiliate link…
Research from the Babraham Institute has developed a method to ‘time jump’ human skin cells by 30 years, turning back the ageing clock for cells without losing their specialised function. Work by researchers in the Institute’s Epigenetics research programme has been able to partly restore the function of older cells, as well as rejuvenating the molecular measures of biological age. The research is published today in the journal eLife and whilst at an early stage of exploration, it could revolutionise regenerative medicine.
What is regenerative medicine?
As we age, our cells’ ability to function declines and the genome accumulates marks of ageing. Regenerative biology aims to repair or replace cells including old ones. One of the most important tools in regenerative biology is our ability to create ‘induced’ stem cells. The process is a result of several steps, each erasing some of the marks that make cells specialised. In theory, these stem cells have the potential to become any cell type, but scientists aren’t yet able to reliably recreate the conditions to re-differentiate stem cells into all cell types.
